News
ABLE member Serum Institute multivalent meningococcal meningitis vaccine gets WHO prequalification
MenFive®, the first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa, has been prequalified by the World Health Organization (WHO)
ABLE member Bugworks gets big funding for antibiotic development
Bengaluru-based startup Bugworks will receive funding and other support from the Global Antibiotic Research & Development Partnership (GARDP), a non-profit co-founded by the WHO, to develop a new antibiotic to treat drug-resistant bacterial infection.
